Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Targeting development microbubble for tumor ultrasound treatment and preparation method thereof

An ultrasonic therapy and microbubble technology, applied in the field of biomedical materials, can solve problems such as poor tumor effect, and achieve the effect of slow release and rapid embolization

Inactive Publication Date: 2019-11-15
SHANDONG BRANDEN MEDICAL DEVICE
View PDF6 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, during the process of microbubble cavitation, the drug particles are released into the tumor vascular embolism material, so that the drug is released slowly, and at the same time of physical embolism, the tumor can be treated with drugs, which solves the problem of patent CN201110074404.1, which can only rely on drugs to treat tumors less effective problem

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Targeting development microbubble for tumor ultrasound treatment and preparation method thereof
  • Targeting development microbubble for tumor ultrasound treatment and preparation method thereof
  • Targeting development microbubble for tumor ultrasound treatment and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031]Example 1: 90 parts of 1,2-distearoyl-sn-glyceryl-3-phosphatidylcholine, 5 parts of 1,2-distearoyl-sn-glyceryl-3-phosphatidylcholine - Polyethylene glycol, 5 parts 1,2-distearoyl-sn-glyceryl-3-phosphatidylcholine-polyethylene glycol-biotin, 250 mg prothrombin, 500 mg fibrinogen, 25 mg fish sulfate Protamine and 4mg of docetaxel were dissolved in 1ml of chloroform and mixed. Blow dry with dry nitrogen at room temperature, dry in vacuum for 4 hours, and completely remove chloroform. Add 5 ml of Tris buffer solution with a pH value of 7.4 (volume ratio: Tris: glycerol: 1,2-propanediol = 8:1:1). Place in a water bath ultrasonic cleaner at 60°C with a vibration frequency of 4500 times / min and a vibration amplitude of 25 mm for 75 seconds to obtain a transparent phospholipid solution. Divide the vials into 5 vials, replace the air in the vials with perfluoropropane, shake for 45 s, centrifuge at 400 g / min for 4 min, and wash with PBS buffer for 3 times. Streptavidin per 1 x...

Embodiment 2

[0032] Example 2: The steps are the same as in Example 1, but the difference is that 1,2-distearoyl-sn-glyceryl-3-phosphatidylcholine is 95 parts, 1,2-distearoyl-sn -Glyceryl-3-phosphatidylcholine-polyethylene glycol is 2.5 parts, 1,2-Distearoyl-sn-glyceroyl-3-phosphatidylcholine-polyethylene glycol-biotin is 2.5 parts .

Embodiment 3

[0033] Example 3: The steps are the same as in Example 1, but the difference is that 1,2-distearoyl-sn-glyceroyl-3-phosphatidylcholine is 93 parts, 1,2-distearoyl-sn -Glyceryl-3-phosphatidylcholine-polyethylene glycol is 3.5 parts, 1,2-Distearoyl-sn-glyceryl-3-phosphatidylcholine-polyethylene glycol-biotin is 3.5 parts .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to a targeting development microbubble for tumor ultrasound treatment. The targeting development microbubble comprises a lipid bilayer shell, a targeting polypeptide or protein derivative fixed at the outer side of the shell, a biological inert gas encased in the shell and blood coagulation factors and drug particles which are dispersed in the shell. The targeting developmentmicrobubble not only can perform high-frequency ultrasonic development to detect and diagnose tumors, but also can specifically adsorb tumor blood vessels through the targeting polypeptide or proteinderivative at the outer side of the lipid bilayer shell, and performs concentrated cavitation under the action of ultrasound to release the blood coagulation factors for rapidly forming capillary embolization, thereby achieving the purpose of treating the tumors. In addition, during microbubble cavitation, the drug particles are released into a tumor vascular embolization substance, so that a drug is slowly released, and the tumors are treated. The targeting development microbubble has extremely important significance for the diagnosis and treatment of the tumors. Furthermore, the invention relates to a preparation method of the targeting development microbubble for the tumor ultrasound treatment.

Description

technical field [0001] The invention belongs to the field of biomedical materials, and in particular relates to a targeted imaging microbubble for ultrasonic treatment of tumors and a preparation method thereof. Background technique [0002] Malignant tumors have always been a problem that plagues the world, and its increasing morbidity and mortality are a major challenge to modern medicine. Tumor tissue is composed of two major system components: tumor blood vessels and tumor cells. The growth and metastasis of tumor cells depend on the formation of new blood vessels. New blood vessels not only provide nutrients and oxygen for the growth of tumor cells, but also effectively transport their metabolites. Without the formation of new blood vessels, the nutrient supply of tumor cells cannot be satisfied. And material excretion, and then severely limit the growth and metastasis of tumor cells. At present, anti-tumor vascular therapy has been considered as an important method f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K49/22A61K45/00A61K38/17A61K38/36A61K38/48A61K47/62A61K47/69A61P35/00
CPCA61K38/1706A61K38/363A61K38/4833A61K45/00A61K49/221A61K49/223A61K47/62A61K47/6925A61P35/00A61K2300/00
Inventor 张海军袁坤山孙丽萍王如蒙徐辉雄张淑欣卢沙
Owner SHANDONG BRANDEN MEDICAL DEVICE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products